Literature DB >> 14638642

Ziprasidone--not an option for serotonin syndrome.

Marshall E Cates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14638642      PMCID： PMC264947     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.

Authors:  E Richelson; T Souder
Journal:  Life Sci       Date:  2000-11-24       Impact factor: 5.037

2.  Serotonin syndrome and atypical antipsychotics.

Authors:  Harprret S Duggal; Joseph Fetchko
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

Review 3.  Serotonin syndrome: a brief review.

Authors:  Philippe Birmes; Dominique Coppin; Laurent Schmitt; Dominique Lauque
Journal:  CMAJ       Date:  2003-05-27       Impact factor: 8.262

Review 4.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 5.  Focus on ziprasidone.

Authors:  B Green
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

Review 6.  Ziprasidone, a new atypical antipsychotic drug.

Authors:  R M Carnahan; B C Lund; P J Perry
Journal:  Pharmacotherapy       Date:  2001-06       Impact factor: 4.705
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.